Print E-mail |
|
IFRS |
IFRS |
FAS |
FAS |
FAS |
||||
| Financial ratios | 2005 |
2004 |
2003 |
2002 |
2001 |
|||
| Net sales | M€ |
197.9 |
178.1 |
189.2 |
196.2 |
183.5 |
||
| exports and international operations | 96.2% |
96.6% |
96.6% |
96.3% |
96.2% |
|||
| Operating profit | M€ |
30.1 |
29.4 |
25.9 |
22.6 |
29.8 |
||
| % of net sales | 15.2% |
16.5% |
13.7% |
11.5% |
16.2% |
|||
| Profit before taxes | M€ |
34.1 |
29.1 |
23.4 |
21.5 |
30.6 |
||
| % of net sales | 17.2% |
16.3% |
12.4% |
10.9% |
16.7% |
|||
| Return on equity (ROE) | 17.5% |
16.0% |
10.4% |
9.5% |
15.6% |
|||
| Return on investment (ROI) | 23.8% |
21.9% |
16.6% |
15.4% |
22.9% |
|||
| Solvency ratio | 80.8% |
82.2% |
84.4% |
83.9% |
82.9% |
|||
| Current ratio | 3.3 |
3.7 |
3.7 |
3.6 |
4.3 |
|||
| Gross capital expenditure | M€ |
8.0 |
4.8 |
14.09 |
28.44 |
12.14 |
||
| % of net sales | 4.0% |
2.7% |
7.4% |
14.5% |
6.6% |
|||
| R&D expenditure | ||||||||
| on machinery and equipment | M€ |
0.3 |
0.1 |
0.4 |
0.5 |
1.1 |
||
| R&D expenditure | M€ |
19.8 |
21.3 |
21.1 |
22.1 |
18.9 |
||
| % of net sales | 10.0% |
12.0% |
11.2% |
11.2% |
10.3% |
|||
| Orderbook on Dec. 31. | M€ |
55.3 |
52.7 |
62.9 |
77.1 |
57.8 |
||
| Average personnel | 1062 |
1092 |
1141 |
1208 |
1115 |
|||
| Shares in figures | ||||||||
| Earnings/share (EPS) | € |
1.42 |
1.20 |
0.83 |
0.75 |
1.21 |
||
| Earnings/share (EPS). calculated taking into account | ||||||||
| the dilution impact of the bond with warrants | € |
1.42 |
1.20 |
0.83 |
0.75 |
1.19 |
||
| Cash flow from business operations/share | € |
2.21 |
2.06 |
1.99 |
1.50 |
0.86 |
||
| Shareholders’ equity/share | € |
8.74 |
7.42 |
7.98 |
7.94 |
7.99 |
||
| Dividend/share | € |
*0.75 |
0.75 |
1.25 |
0.55 |
0.55 |
||
| Dividend/earnings | % |
**52.8% |
62.5% |
150.8% |
72.4% |
45.4% |
||
| Effective dividend yield *** | % |
3.1% |
4.1% |
5.1% |
2.4% |
2.0% |
||
| Price/earnings (P/E) | 16.90 |
15.17 |
29.55 |
30.51 |
22.6 |
|||
| A-share trading | ||||||||
| highest | € |
24.74 |
24.50 |
25.00 |
30.30 |
36.25 |
||
| lowest | € |
18.48 |
17.25 |
16.70 |
18.81 |
23.80 |
||
| weighted average | € |
22.15 |
20.03 |
19.95 |
25.78 |
29.85 |
||
| at balance sheet date | € |
24.00 |
18.20 |
24.50 |
22.98 |
27.30 |
||
| Market capitalisation at | ||||||||
| balance sheet date *** | M€ |
424.0 |
318.1 |
428.2 |
400.7 |
471.1 |
||
| A-shares traded | ||||||||
| traded | pcs |
2 442 168 |
1 635 934 |
1 495 572 |
1 607 165 |
3 860 888 |
||
| % of entire series | % |
17.1% |
11.6% |
10.6% |
11.5% |
27.9% |
||
| Adjusted number of shares | pcs |
17 532 161 |
17 479 000 |
17 471 904 |
17 351 471 |
17 242 655 |
||
| A-shares | pcs |
14 256 165 |
14 065 715 |
14 063 215 |
13 935 686 |
13 818 354 |
||
| K-shares | pcs |
3 409 285 |
3 413 285 |
3 415 785 |
3 415 785 |
3 424 301 |
||
| Number of shares at Dec. 31 | pcs |
17 665 450 |
17 479 000 |
17 479 000 |
17 437 000 |
17 257 000 |
||
* Proposal by the Board of Directors
** Calculated according to the proposal by the Board of Directors
*** Value of A and K shares is here calculated to be equal